| Dr Larry G Kutina, DDS | |
|
3820 6th Street, Great Bend, KS 67530 | |
| (620) 792-2114 | |
| (620) 792-3029 |
| Full Name | Dr Larry G Kutina |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 3820 6th Street, Great Bend, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912060435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | KS6481 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Larry G Kutina, DDS 3820 6th Street, Great Bend, KS 67530 Ph: (620) 792-2114 | Dr Larry G Kutina, DDS 3820 6th Street, Great Bend, KS 67530 Ph: (620) 792-2114 |
News Archive
A new study released today estimates that the global initiative to eradicate polio could provide net benefits of at least US$40-50 billion if transmission of wild polioviruses is interrupted within the next five years. The study provides the first rigorous evaluation of the benefits and costs of the Global Polio Eradication Initiative (GPEI)-the single largest project ever undertaken by the global health community. The study comes at a crucial time-following an outbreak in the Republic of the Congo and one in Tajikistan earlier this year-that highlight the risk of delays in finishing the job on polio.
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study by Arizona State University scientist Qiang Chen and his colleagues.
New preclinical results from a study led by David Masopust of the University of Minnesota in Minneapolis, USA, show that a Had5-based vaccine targeting the nucleocapsid protein can also elicit a protective immune response.
› Verified 6 days ago
Abdul Rahman Yakan, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1821 Kansas Ave, Great Bend, KS 67530 Phone: 620-603-6838 | |
Randall D Reinhardt, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1821 Kansas Ave, Great Bend, KS 67530 Phone: 620-603-6838 Fax: 620-792-5742 | |
Dr. Ross Alan Hildebrand, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3822 6th St, Great Bend, KS 67530 Phone: 620-792-1231 Fax: 620-792-5146 | |
Dr. Mark A Leiker, DDS MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2023 Washington St, Great Bend, KS 67530 Phone: 620-792-6640 Fax: 620-792-6649 | |
Dr. George M Allison, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1037 Sheridan St, Great Bend, KS 67530 Phone: 620-792-4205 Fax: 620-793-3190 | |
Dr. Wonsik Jung, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1821 Kansas Ave, Great Bend, KS 67530 Phone: 620-603-6838 | |
Dr. Tatum Dunekack, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2124 Washington St, Great Bend, KS 67530 Phone: 620-792-7690 Fax: 620-792-7719 |